Pharmaceuticals

Global Biosimilar Monoclonal Antibodies Market Research Report 2016

  • QYR682573
  • 106 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Biosimilar Monoclonal Antibodies

Revenue, means the sales value of Biosimilar Monoclonal Antibodies

This report studies Biosimilar Monoclonal Antibodies in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

Celltrion

Boehringer Ingelheim

Dr Reddy’s

Sandoz

Zydus

Samsung

Amgen

Hospira

Shanghai CP Guojian Pharmaceutical

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Biosimilar Monoclonal Antibodies in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on consumption, market share and growth rate of Biosimilar Monoclonal Antibodies in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global Biosimilar Monoclonal Antibodies Market Research Report 2016

1 Biosimilar Monoclonal Antibodies Market Overview

1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies

1.2 Biosimilar Monoclonal Antibodies Segment by Type

1.2.1 Global Production Market Share of Biosimilar Monoclonal Antibodies by Type in 2015

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 Biosimilar Monoclonal Antibodies Segment by Application

1.3.1 Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Biosimilar Monoclonal Antibodies Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Biosimilar Monoclonal Antibodies (2011-2021)

2 Global Biosimilar Monoclonal Antibodies Market Competition by Manufacturers

2.1 Global Biosimilar Monoclonal Antibodies Production and Share by Manufacturers (2015 and 2016)

2.2 Global Biosimilar Monoclonal Antibodies Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Biosimilar Monoclonal Antibodies Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Sales Area and Product Type

2.5 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends

2.5.1 Biosimilar Monoclonal Antibodies Market Concentration Rate

2.5.2 Biosimilar Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Biosimilar Monoclonal Antibodies Production, Revenue (Value) by Region (2011-2016)

3.1 Global Biosimilar Monoclonal Antibodies Production and Market Share by Region (2011-2016)

3.2 Global Biosimilar Monoclonal Antibodies Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Biosimilar Monoclonal Antibodies Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Biosimilar Monoclonal Antibodies Consumption by Regions (2011-2016)

4.2 North America Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Biosimilar Monoclonal Antibodies Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Biosimilar Monoclonal Antibodies Production, Revenue (Value), Price Trend by Type

5.1 Global Biosimilar Monoclonal Antibodies Production and Market Share by Type (2011-2016)

5.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)

5.3 Global Biosimilar Monoclonal Antibodies Price by Type (2011-2016)

5.4 Global Biosimilar Monoclonal Antibodies Production Growth by Type (2011-2016)

6 Global Biosimilar Monoclonal Antibodies Market Analysis by Application

6.1 Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Application (2011-2016)

6.2 Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Biosimilar Monoclonal Antibodies Manufacturers Profiles/Analysis

7.1 Celltrion

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Celltrion Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Boehringer Ingelheim

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Dr Reddy’s

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 Sandoz

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Sandoz Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Zydus

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Zydus Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Samsung

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Samsung Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Amgen

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Amgen Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Hospira

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Hospira Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Shanghai CP Guojian Pharmaceutical

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

8 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis

8.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Biosimilar Monoclonal Antibodies Market Forecast (2016-2021)

12.1 Global Biosimilar Monoclonal Antibodies Production, Revenue Forecast (2016-2021)

12.2 Global Biosimilar Monoclonal Antibodies Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Biosimilar Monoclonal Antibodies Production Forecast by Type (2016-2021)

12.4 Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2016-2021)

12.5 Biosimilar Monoclonal Antibodies Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Table and Figures

Figure Picture of Biosimilar Monoclonal Antibodies

Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Biosimilar Monoclonal Antibodies Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Biosimilar Monoclonal Antibodies Production of Key Manufacturers (2015 and 2016)

Table Global Biosimilar Monoclonal Antibodies Production Share by Manufacturers (2015 and 2016)

Figure 2015 Biosimilar Monoclonal Antibodies Production Share by Manufacturers

Figure 2016 Biosimilar Monoclonal Antibodies Production Share by Manufacturers

Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers

Table 2016 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers

Table Global Market Biosimilar Monoclonal Antibodies Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Biosimilar Monoclonal Antibodies Average Price of Key Manufacturers in 2015

Table Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area

Table Manufacturers Biosimilar Monoclonal Antibodies Product Type

Figure Biosimilar Monoclonal Antibodies Market Share of Top 3 Manufacturers

Figure Biosimilar Monoclonal Antibodies Market Share of Top 5 Manufacturers

Table Global Biosimilar Monoclonal Antibodies Production by Regions (2011-2016)

Figure Global Biosimilar Monoclonal Antibodies Production and Market Share by Regions (2011-2016)

Figure Global Biosimilar Monoclonal Antibodies Production Market Share by Regions (2011-2016)

Figure 2015 Global Biosimilar Monoclonal Antibodies Production Market Share by Regions

Table Global Biosimilar Monoclonal Antibodies Revenue by Regions (2011-2016)

Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions (2011-2016)

Table 2015 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions

Table Global Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Table China Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Table India Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Biosimilar Monoclonal Antibodies Consumption Market by Regions (2011-2016)

Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions (2011-2016)

Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions

Table North America Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (2011-2016)

Table Europe Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (2011-2016)

Table China Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (2011-2016)

Table Japan Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (2011-2016)

Table India Biosimilar Monoclonal Antibodies Production, Consumption, Import & Export (2011-2016)

Table Global Biosimilar Monoclonal Antibodies Production by Type (2011-2016)

Table Global Biosimilar Monoclonal Antibodies Production Share by Type (2011-2016)

Figure Production Market Share of Biosimilar Monoclonal Antibodies by Type (2011-2016)

Figure 2015 Production Market Share of Biosimilar Monoclonal Antibodies by Type

Table Global Biosimilar Monoclonal Antibodies Revenue by Type (2011-2016)

Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Biosimilar Monoclonal Antibodies by Type (2011-2016)

Figure 2015 Revenue Market Share of Biosimilar Monoclonal Antibodies by Type

Table Global Biosimilar Monoclonal Antibodies Price by Type (2011-2016)

Figure Global Biosimilar Monoclonal Antibodies Production Growth by Type (2011-2016)

Table Global Biosimilar Monoclonal Antibodies Consumption by Application (2011-2016)

Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2011-2016)

Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2015

Table Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2011-2016)

Figure Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2011-2016)

Table Celltrion Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Celltrion Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Celltrion Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Dr Reddy’s Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Dr Reddy’s Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Dr Reddy’s Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Sandoz Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sandoz Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Sandoz Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Zydus Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Zydus Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Zydus Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Samsung Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Samsung Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Samsung Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amgen Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Hospira Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Hospira Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Shanghai CP Guojian Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2011-2016)

Figure Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies

Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies

Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis

Table Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015

Table Major Buyers of Biosimilar Monoclonal Antibodies

Table Distributors/Traders List

Figure Global Biosimilar Monoclonal Antibodies Production and Growth Rate Forecast (2016-2021)

Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)

Table Global Biosimilar Monoclonal Antibodies Production Forecast by Regions (2016-2021)

Table Global Biosimilar Monoclonal Antibodies Consumption Forecast by Regions (2016-2021)

Table Global Biosimilar Monoclonal Antibodies Production Forecast by Type (2016-2021)

Table Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370